Theseus Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 14, 2022 / 07:30PM GMT
Unidentified Analyst -

Good afternoon. I'm going to read the disclosure, first of all. For important disclosures, please see the Morgan Stanley Research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

Well, great. Well, welcome, Tim.

Timothy P. Clackson - Theseus Pharmaceuticals, Inc. - CEO, President & Director

Thank you.

Unidentified Analyst -

Clackson, CEO, Theseus Pharmaceuticals. Perhaps before diving into some granular questions, it would be great to just provide an overview on the company's focus with respect to cancer-resistant and pan-variant TKIs. And why this is important.

Timothy P. Clackson - Theseus Pharmaceuticals, Inc. - CEO, President & Director

Great. I'd be happy to. So first, thanks, Jessica, for the opportunity. And it's great to have a chance to describe what

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot